Summary
Although cancer in pregnancy (CIP) is rare (one in 1000-2000 pregnancies), it has an important impact on society as it annually affects more than 200,000 pregnant women worldwide. The ERC-CoG project “CRADLE”, has led to the finding that management of cancer in pregnancy requires a specialized multidisciplinary care of not only physicians within the oncology field but also in gynaecology, obstetrics, perinatology and psychology. However, as CIP is a rare event, most physicians are rarely confronted with pregnant women with cancer and therefore, lack the expertise manage these cases. Moreover, many geographical and logistic barriers might impede community-based hospitals and/or patients access to multidisciplinary tumour boards in referral hospitals. This results in a staggering number of patients that are treated with suboptimal care.
As a result of these findings, Prof. Amant and his CRADLE team spearheaded the creation of an email-based Dutch-Belgian tumor advisory board, that is highly integrative and specialised in the cancer in pregnancy field. The main aim of this board is to remotely discuss CRADLE cases but also to provide specialized advice to hospitals without specialized resources or with important geographical and logistic barriers.
In NIMBUS4CIP, we plan to validate the societal and commercial value of this Dutch-Belgian cancer in pregnancy platform. First, we will technically optimize the board by creating a web-based software (weCRADLE) that will streamline and improve the efficiency of case management. Next, we will validate in a prospective pilot study whether patient management using weCRADLE leads to improved oncological, obstetrical and neonatal outcomes. Finally, we will evaluate weCRADLE’s intellectual property position and the commercialization potential as a tool to remotely offer support to non-specialized physicians.
As a result of these findings, Prof. Amant and his CRADLE team spearheaded the creation of an email-based Dutch-Belgian tumor advisory board, that is highly integrative and specialised in the cancer in pregnancy field. The main aim of this board is to remotely discuss CRADLE cases but also to provide specialized advice to hospitals without specialized resources or with important geographical and logistic barriers.
In NIMBUS4CIP, we plan to validate the societal and commercial value of this Dutch-Belgian cancer in pregnancy platform. First, we will technically optimize the board by creating a web-based software (weCRADLE) that will streamline and improve the efficiency of case management. Next, we will validate in a prospective pilot study whether patient management using weCRADLE leads to improved oncological, obstetrical and neonatal outcomes. Finally, we will evaluate weCRADLE’s intellectual property position and the commercialization potential as a tool to remotely offer support to non-specialized physicians.
Unfold all
/
Fold all
More information & hyperlinks
| Web resources: | https://cordis.europa.eu/project/id/875174 |
| Start date: | 01-03-2020 |
| End date: | 31-08-2021 |
| Total budget - Public funding: | - 150 000,00 Euro |
Cordis data
Original description
Although cancer in pregnancy (CIP) is rare (one in 1000-2000 pregnancies), it has an important impact on society as it annually affects more than 200,000 pregnant women worldwide. The ERC-CoG project “CRADLE”, has led to the finding that management of cancer in pregnancy requires a specialized multidisciplinary care of not only physicians within the oncology field but also in gynaecology, obstetrics, perinatology and psychology. However, as CIP is a rare event, most physicians are rarely confronted with pregnant women with cancer and therefore, lack the expertise manage these cases. Moreover, many geographical and logistic barriers might impede community-based hospitals and/or patients access to multidisciplinary tumour boards in referral hospitals. This results in a staggering number of patients that are treated with suboptimal care.As a result of these findings, Prof. Amant and his CRADLE team spearheaded the creation of an email-based Dutch-Belgian tumor advisory board, that is highly integrative and specialised in the cancer in pregnancy field. The main aim of this board is to remotely discuss CRADLE cases but also to provide specialized advice to hospitals without specialized resources or with important geographical and logistic barriers.
In NIMBUS4CIP, we plan to validate the societal and commercial value of this Dutch-Belgian cancer in pregnancy platform. First, we will technically optimize the board by creating a web-based software (weCRADLE) that will streamline and improve the efficiency of case management. Next, we will validate in a prospective pilot study whether patient management using weCRADLE leads to improved oncological, obstetrical and neonatal outcomes. Finally, we will evaluate weCRADLE’s intellectual property position and the commercialization potential as a tool to remotely offer support to non-specialized physicians.
Status
CLOSEDCall topic
ERC-2019-POCUpdate Date
27-04-2024
Images
No images available.
Geographical location(s)
Search
